Dr. Rath Health Foundation

Dr. Rath Health Foundation

Responsibility for a healthy world Dr. Rath Research Institute 100+ Studies Published In PubMed

Dr. Rath Health Foundation Newsletter

July 17, 2014

If you would like to receive our newsletters regularly, please send us an email.

Latest News Updates

Keep up-to-date on the latest health and politics news with our regular updates and analysis of the key stories from around the world.


For more natural health news, click here.
See also our 2001-2013 news archive, by clicking here.

Study examines dietary fatty acid intake,
risk for Lou Gehrig disease

July 14, 2014

Eating foods high in ω-3 polyunsaturated fatty acids (PUFAs) from vegetable and marine sources may help reduce the risk for amyotrophic lateral sclerosis (ALS), the fatal neurodegenerative disease commonly referred to as Lou Gehrig's disease.
Read article at medicalxpress.com

DHA omega-3 linked to
‘significantly improved periodontal outcomes’: Harvard data

July 14, 2014

Scientists from Harvard report that supplementation with DHA (docosahexaenoic acid) omega-3 may improve periodontal outcomes in people with periodontitis.
Read article at nutraingredients-usa.com

Daily vitamin D dose linked to cancer survival

July 10, 2014

A daily vitamin pill could increase the odds of surviving cancer, research suggests.
Read article in the Daily Express (UK)


For more pharma "business with disease" news, click here.
See also our 2001-2013 news archive, by clicking here.

China charges GSK-linked investigator and his wife
for 'illegally obtaining private information'

July 14, 2014

The charges are the latest chapter in an extremely damaging story for Glaxo, which is accused by prosecutors of having bribed its way to winning drug supply contracts in the company.
Read article in the Independent (UK)

Big pharma weigh sell-off of old drugs
Drug groups have begun discussions with private equity players about the potential sale of their off-patent medicines, but hurdles remain

July 12, 2014

The world’s biggest drugs companies are in talks with bankers about ways to cash in their multi-billion pound portfolios of older drugs in the face of declining sales.
Read article in the Daily Telegraph (UK)

Comment: This story provides a good illustration of how the primary driving force for the ‘business with disease’ is not health, but shareholder profits. Once a pharma company’s drugs lose patent protection they immediately face competition from generic rivals producing cheaper versions of them. This inevitably results in declining sales of the original patented drugs, falling profits and shareholder pressure to create new ones. The extent to which the industry seeks to hide the fraudulent nature of this business model from patients is illustrated in this article by the use of disingenuous phrases such as “portfolio rationalisation” and “shrinking to grow”.

Research finds association between certain pain relievers
and heart attack

July 10, 2014

A University of Florida study has found that the regular use of some non-steroidal anti-inflammatory drugs, or NSAIDs, increases the risk of stroke, heart attack and death in postmenopausal women.
Read article at medicalxpress.com

Chemotherapy shown to affect memory in young cancer patients

July 8, 2014

A significant number of young cancer patients suffer memory related side effects from chemotherapy according to a study by The University of Manchester to be announced at Teenage Cancer Trust's International Conference on Teenage and Young Adult Cancer, Royal Society of Medicine.
Read article at medicalxpress.com

Comment: Unlike vitamin C which has been scientifically proven to be selectively toxic to cancer cells, chemotherapy is unable to distinguish between cancer cells and healthy cells. As a result, it damages all cells in the body indiscriminately and has justifiably been compared to a “shotgun” approach. To make things even worse, chemotherapy particularly affects those healthy cells in the body that are multiplying rapidly, such as the white blood cells of the immune system. Thus, at a time when the body of a cancer patient has the greatest need for effective defence, the immune cells are being systematically destroyed by highly toxic procedures. The future of medicine doesn’t have to be like this, however. There are already natural health approaches that have been shown to block ALL key mechanisms that make cancer a deadly disease. To learn about them, click here.


For more GMO news, click here.
See also our 2001-2013 news archive, by clicking here.

‘No to TAFTA’: France celebs campaign against EU-US trade deal, sign petition

July 11, 2014

One hundred French celebrities have launched a campaign against the upcoming TAFTA deal between the US and Europe. The protesters say the new treaty will lower economic standards and bring a large influx of GMO products from the US.
Read article at rt.com (Russia)

Salvadoran Farmers Successfully Oppose the Use of Monsanto Seeds

July 8, 2014

Farmers across El Salvador united to block a stipulation in a US aid package to their country that would have indirectly required the purchase of Monsanto genetically modified (GM) seeds.
Read article at truth-out.org


For more health-related news, click here.
See also our 2001-2013 news archive, by clicking here.

Clear differences between organic and non-organic food,
study finds

July 11, 2014

Organic food has more of the antioxidant compounds linked to better health than regular food, and lower levels of toxic metals and pesticides, according to the most comprehensive scientific analysis to date.
Read article in The Guardian (UK)

Place Mushrooms in Sunlight to Get Your Vitamin D

July 10, 2014

Vitamin D is an essential vitamin that boosts the immune system and plays vital roles in human metabolism. Did you know that tasty mushrooms are one source for vitamin D, and that you can naturally multiply their levels by exposing them to sunlight?
Read article at greenmedinfo.com

Controversial pesticides killing wild birds as well as bees

July 9, 2014

Declining numbers of starlings and tree sparrows in the Netherlands linked to chemical used to protect crops from insects.
Read article in the Daily Telegraph (UK)


For more political news, visit the news pages on the website of the International Alliance for Health, Peace and Social Justice, and the news page on the European Referendum Initiative website. Citizens of the UK can find additional UK-orientated news stories on the Reject the EU website.

The Illusion of Foreign Investment Growth? Africa Must Break With the World Capitalist System
People want genuine development as demonstrations, strikes spread across continent

July 8, 2014

How long and deep can the current character of Foreign Direct Investment (FDI) penetrate the social legacy of colonialism and neo-colonialism in Africa? Proclamations of economic growth throughout the continent are being received with much skepticism and consequently prompting the desire among many to address the persistent poverty, inefficiency and growing class divisions.
Read article on the Centre for Research on Globalization website

Comment: One of the most insidious forms of colonialism in Africa today is pharmaceutical colonialism. Primarily conducted via the drug industry’s disingenuous promotion of so-called “antiretroviral” drugs (ARVs) to treat AIDS, multinational pharmaceutical companies have essentially now replaced the colonial empires of previous centuries. While AIDS has been a serious health problem ever since its first appearance thirty years or so ago, it has been deliberately and strategically developed into a global health epidemic by the very interest group that pretends to fight it: the pharmaceutical investment business. Pharmaceutical multinationals are particularly focusing their promotion of the AIDS epidemic on the developing world for two main reasons: First, they depend on the continuation and expansion of this disease as a multibillion dollar marketplace for patented ARV drugs. Secondly, they force the governments of the developing world to spend ever-increasing amounts of their national budgets on drugs – thereby cementing the economic dependency of poor countries upon the industrialized world. To learn more about pharmaceutical colonialism, read the Dr. Rath Health Foundation’s book, End AIDS.

Who lobbies most on TTIP?

July 8, 2014

Do you wonder which businesses are pushing most for the proposed EU-US trade deal TTIP? Or where they come from? And who has most access to EU negotiators? CEO’s at-a-glance info-graphics shine a light on the corporate lobby behind the TTIP talks.
Read article on the Corporate Europe Observatory website

Comment: The so-called Transatlantic Trade and Investment Partnership, also known as TAFTA, is being negotiated between the Obama Administration and unelected bureaucrats of the so-called "Brussels European Union“. Conducted in clandestine, the talks are taking place under heavy influence of the multi-billion dollar global pharmaceutical investment industry. Under the guise of "free trade” and "international harmonization“, these negotiations primarily serve the goal of protecting the trillion-dollar-per-year global business with patented pharmaceutical drugs. To learn more, visit the special Say NO to TAFTA campaign page on the website of our Foundation.


Back to the Newsletter Archive…